FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disord...

Full description

Saved in:
Bibliographic Details
Main Authors HEER, JAG PAUL, KEYAERTS, JEAN
Format Patent
LanguageEnglish
French
Published 05.10.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 5,7,8,15-tetrahydro-6H-8,15- methanobenzimidazo[1,2-b][2,5]benzodiazocin-6-one derivatives and analogs thereof. L'invention concerne une série de dérivés d'imidazole pentacycliques condensés qui sont de puissants modulateurs de l'activité du TNFa humain, et sont ainsi efficaces dans le traitement et/ou la prévention de diverses affections humaines, dont les troubles auto-immuns et inflammatoires ; les troubles neurologiques et neurodégénératifs ; la douleur et les troubles nociceptifs ; les troubles cardiovasculaires ; les troubles métaboliques ; les troubles oculaires ; et les troubles oncologiques. En particulier, la présente invention concerne les dérivés de 5,7,8,15-tétrahydro-6H-8,15-méthanobenzimidazo[1,2-b][2,5]benzodiazocin-6-one et des analogues de ceux-ci.
Bibliography:Application Number: CA20173018907